Thrombomodulin – Function, Significance & Therapy
Thrombomodulin is a glycoprotein on the surface of vascular endothelial cells that plays a key role in inhibiting blood coagulation and regulating inflammation.
Things worth knowing about "Thrombomodulin"
Thrombomodulin is a glycoprotein on the surface of vascular endothelial cells that plays a key role in inhibiting blood coagulation and regulating inflammation.
What is Thrombomodulin?
Thrombomodulin (also known as CD141 or BDCA-3) is a transmembrane glycoprotein expressed primarily on the surface of endothelial cells – the cells lining the inner walls of blood vessels. It acts as a critical natural anticoagulant and plays a central role in maintaining the balance between clot formation and clot inhibition in the bloodstream.
Mechanism of Action
Thrombomodulin works by binding thrombin – a key enzyme in blood coagulation – and fundamentally altering its function. Under normal circumstances, thrombin promotes clotting by converting fibrinogen to fibrin and activating platelets. However, when thrombin binds to thrombomodulin, it loses these procoagulant properties and acquires new anticoagulant functions:
- Activation of Protein C: The thrombin-thrombomodulin complex efficiently activates Protein C, a major natural anticoagulant. Activated Protein C (APC), together with its cofactor Protein S, degrades coagulation factors Va and VIIIa, thereby inhibiting further clot formation.
- Activation of TAFI: The complex also activates thrombin-activatable fibrinolysis inhibitor (TAFI), which modulates the breakdown of blood clots (fibrinolysis).
- Anti-inflammatory effects: Thrombomodulin has intrinsic anti-inflammatory properties through its lectin-like domain, which inhibits certain pro-inflammatory mediators such as high-mobility group box 1 (HMGB1).
Clinical Significance
Thrombomodulin has considerable clinical relevance across a range of diseases and pathological conditions:
Vascular Disease and Thrombosis
Reduced expression or impaired function of thrombomodulin on endothelial cells can increase the risk of thrombosis. Mutations in the thrombomodulin gene (THBD) have been associated with an elevated risk of venous thromboembolism (blood clots in veins), myocardial infarction, and stroke.
Disseminated Intravascular Coagulation (DIC)
In disseminated intravascular coagulation – a life-threatening disorder characterized by simultaneous excessive clotting and bleeding – thrombomodulin function is severely compromised. A recombinant thrombomodulin preparation (thrombomodulin alfa) is approved in Japan for the treatment of DIC and is under investigation in clinical trials in other countries.
Sepsis
In severe sepsis (life-threatening infection), thrombomodulin is shed from the endothelial surface, contributing to increased coagulation activity and systemic inflammation. Soluble thrombomodulin in the blood therefore serves as a biomarker for endothelial injury and sepsis severity.
Renal Disease
Thrombomodulin is also implicated in thrombotic microangiopathy (TMA), a group of disorders characterized by damage to small blood vessels. Mutations in the THBD gene have been described in patients with hemolytic uremic syndrome (HUS).
Thrombomodulin as a Biomarker
Soluble thrombomodulin released into the circulation following endothelial injury can be measured in laboratory tests and serves as a marker of endothelial dysfunction. Elevated levels are observed in sepsis, diabetes mellitus, cardiovascular disease, and after organ transplantation.
Therapeutic Applications
Based on the anticoagulant and anti-inflammatory properties of thrombomodulin, recombinant preparations have been developed for clinical use:
- Thrombomodulin alfa (ART-123): A recombinant soluble thrombomodulin derivative approved in Japan for the treatment of disseminated intravascular coagulation (DIC).
- Ongoing clinical trials are investigating its use in sepsis, acute respiratory distress syndrome (ARDS), and other conditions involving endothelial injury.
References
- Esmon CT. - The roles of protein C and thrombomodulin in the regulation of blood coagulation. - Journal of Biological Chemistry, 2003.
- Ito T, Thachil J, Asakura H et al. - Thrombomodulin in disseminated intravascular coagulation and other conditions. - Annals of Intensive Care, 2019.
- World Health Organization (WHO) - Guidelines on the evaluation and management of sepsis and coagulation disorders. - WHO Technical Report, 2020.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.